Safe To Treat HER2-positive Breast Cancer With Trastuzumab And Adjuvant Radiation, Study Finds
Tuesday, November 3, 2009 - 11:35
in Health & Medicine
Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is trastuzumab (herceptin) -- typically used in combination with chemotherapy. However, a new study reports that it may be safe to treat these patients with both trastuzumab and adjuvant radiation therapy.
Read the whole article on Science Daily
More from Science Daily
Related
- Study finds it's safe to treat HER2-positive breast cancer with trastuzumab and adjuvant radiationTue, 3 Nov 2009, 10:46:33 EST
- Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancerThu, 28 May 2009, 17:23:59 EDT
- M. D. Anderson study finds change in HER2 status after treatment with HerceptinThu, 4 Sep 2008, 14:14:57 EDT
- Triple drug combination is promising option to treat metastatic HER2+ breast cancerFri, 15 May 2009, 9:36:18 EDT
- HER2 levels may aid in treatment selection for metastatic breast cancerTue, 2 Dec 2008, 10:49:47 EST